Stryker Total Liabilities and Share Holders Equity 2010-2024 | SYK

Stryker total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Stryker total liabilities and share holders equity for the quarter ending September 30, 2024 was $43.833B, a 15.22% increase year-over-year.
  • Stryker total liabilities and share holders equity for 2023 was $39.912B, a 8.21% increase from 2022.
  • Stryker total liabilities and share holders equity for 2022 was $36.884B, a 6.51% increase from 2021.
  • Stryker total liabilities and share holders equity for 2021 was $34.631B, a 0.88% increase from 2020.
Stryker Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $39,912
2022 $36,884
2021 $34,631
2020 $34,330
2019 $30,167
2018 $27,229
2017 $22,197
2016 $20,435
2015 $16,223
2014 $17,279
2013 $15,743
2012 $13,206
2011 $12,146
2010 $10,895
2009 $9,071
Stryker Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $43,833
2024-06-30 $39,130
2024-03-31 $39,402
2023-12-31 $39,912
2023-09-30 $38,042
2023-06-30 $37,409
2023-03-31 $36,830
2022-12-31 $36,884
2022-09-30 $35,983
2022-06-30 $36,032
2022-03-31 $36,137
2021-12-31 $34,631
2021-09-30 $34,145
2021-06-30 $33,698
2021-03-31 $33,455
2020-12-31 $34,330
2020-09-30 $32,286
2020-06-30 $31,483
2020-03-31 $29,440
2019-12-31 $30,167
2019-09-30 $26,659
2019-06-30 $26,354
2019-03-31 $25,937
2018-12-31 $27,229
2018-09-30 $22,084
2018-06-30 $21,570
2018-03-31 $22,133
2017-12-31 $22,197
2017-09-30 $21,485
2017-06-30 $21,292
2017-03-31 $20,517
2016-12-31 $20,435
2016-09-30 $20,187
2016-06-30 $20,520
2016-03-31 $19,668
2015-12-31 $16,223
2015-09-30 $15,917
2015-06-30 $16,819
2015-03-31 $16,580
2014-12-31 $17,279
2014-09-30 $17,515
2014-06-30 $17,229
2014-03-31 $16,159
2013-12-31 $15,743
2013-09-30 $14,883
2013-06-30 $14,382
2013-03-31 $14,089
2012-12-31 $13,206
2012-09-30 $12,777
2012-06-30 $12,262
2012-03-31 $12,459
2011-12-31 $12,146
2011-09-30 $12,083
2011-06-30 $11,596
2011-03-31 $11,231
2010-12-31 $10,895
2010-09-30 $10,772
2010-06-30 $10,060
2010-03-31 $10,098
2009-12-31 $9,071
2009-09-30 $8,459
2009-06-30 $7,924
2009-03-31 $7,585
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $148.171B $20.498B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $203.157B 25.91
Boston Scientific (BSX) United States $133.131B 38.28
EssilorLuxottica (ESLOY) France $113.461B 0.00
Medtronic (MDT) Ireland $109.010B 16.19
Haleon (HLN) United Kingdom $42.913B 27.88
Lonza Group Ag (LZAGY) Switzerland $42.122B 0.00
GE HealthCare Technologies (GEHC) United States $37.701B 19.56
ResMed (RMD) United States $34.955B 28.72
Terumo (TRUMY) Japan $29.203B 41.24
Koninklijke Philips (PHG) Netherlands $24.410B 18.68
Zimmer Biomet Holdings (ZBH) United States $22.087B 14.06
Insulet (PODD) United States $18.377B 73.18
Baxter (BAX) United States $16.604B 10.80
Smith & Nephew SNATS (SNN) United Kingdom $11.153B 0.00
BellRing Brands (BRBR) United States $9.468B 37.96
Bio-Rad Laboratories (BIO) United States $8.977B 30.51
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $5.523B 12.83
TG Therapeutics (TGTX) United States $4.720B 0.00
Haemonetics (HAE) United States $4.260B 20.79
ICU Medical (ICUI) United States $4.155B 39.56
Prestige Consumer Healthcare (PBH) United States $4.074B 20.26
Perrigo (PRGO) Ireland $3.716B 10.94
Envista Holdings (NVST) United States $3.487B 25.97
Neogen (NEOG) United States $3.270B 37.72
Agios Pharmaceuticals (AGIO) United States $3.103B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.789B 17.89
QuidelOrtho (QDEL) United States $2.595B 16.70
Warby Parker (WRBY) United States $2.344B 0.00
LeMaitre Vascular (LMAT) United States $2.332B 56.69
Green Thumb Industries (GTBIF) United States $1.964B 34.37
AtriCure (ATRC) United States $1.772B 0.00
InMode (INMD) Israel $1.487B 8.94
Curaleaf Holdings (CURLF) Canada $1.348B 0.00
AdaptHealth (AHCO) United States $1.311B 9.37
Maravai LifeSciences Holdings (MRVI) United States $1.168B 0.00
BioLife Solutions (BLFS) United States $1.041B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.96
Owens & Minor (OMI) United States $0.957B 7.48
CeriBell (CBLL) United States $0.916B 0.00
National Vision Holdings (EYE) United States $0.888B 29.68
Capricor Therapeutics (CAPR) United States $0.839B 0.00
Evolus (EOLS) United States $0.785B 0.00
Verano Holdings (VRNOF) United States $0.608B 0.00
Cresco Labs (CRLBF) United States $0.596B 0.00
VAREX IMAGING (VREX) United States $0.596B 26.47
Surmodics (SRDX) United States $0.559B 0.00
Quanterix (QTRX) United States $0.424B 0.00
Canopy Growth (CGC) Canada $0.404B 0.00
Valneva SE (VALN) France $0.370B 0.00
ZimVie (ZIMV) United States $0.363B 30.63
Omeros (OMER) United States $0.349B 0.00
Viemed Healthcare (VMD) United States $0.335B 31.89
Biote (BTMD) United States $0.330B 7.25
Sanara MedTech (SMTI) United States $0.323B 0.00
Cerus (CERS) United States $0.312B 0.00
OraSure Technologies (OSUR) United States $0.288B 19.30
Zynex (ZYXI) United States $0.249B 52.13
TerrAscend (TSNDF) Canada $0.243B 0.00
Aurora Cannabis (ACB) Canada $0.229B 0.00
Utah Medical Products (UTMD) United States $0.219B 15.15
MacroGenics (MGNX) United States $0.218B 0.00
High Tide (HITI) Canada $0.215B 89.00
Sanuwave Health (SNWV) United States $0.195B 2.74
Jin Medical (ZJYL) China $0.188B 0.00
Zevia PBC (ZVIA) United States $0.162B 0.00
Brainsway (BWAY) Israel $0.161B 96.70
Organigram Holdings (OGI) Canada $0.158B 0.00
FitLife Brands (FTLF) United States $0.143B 17.98
TriSalus Life Sciences (TLSI) United States $0.126B 0.00
Quipt Home Medical (QIPT) United States $0.106B 0.00
Fonar (FONR) United States $0.093B 10.54
Oramed Pharmaceuticals (ORMP) United States $0.093B 23.00
Veru (VERU) United States $0.092B 0.00
Ayr Wellness (AYRWF) United States $0.082B 0.00
Rockwell Medical (RMTI) United States $0.080B 41.50
Modular Medical (MODD) United States $0.073B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
Cellectar Biosciences (CLRB) United States $0.066B 0.00
InterCure (INCR) Israel $0.063B 0.00
Exagen (XGN) United States $0.062B 0.00
MariMed (MRMD) United States $0.059B 0.00
Safety Shot (SHOT) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.052B 0.00
Apyx Medical (APYX) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.026B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
Nephros (NEPH) United States $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.17
SNDL (SNDL) Canada $0.000B 0.00